Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update on synbiotic therapy assessing effects on intestinal microbiota and insulin resistance in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hasanuddin University | Conditions: Obesity, Insulin Resistance | Phase 4 | Status: COMPLETED